Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.
Hamaï A, Duperrier-Amouriaux K, Pignon P, Raimbaud I, Memeo L, Colarossi C, Canzonieri V, Perin T, Classe JM, Campone M, Jézéquel P, Campion L, Ayyoub M, Valmori D.
Hamaï A, et al. Among authors: raimbaud i.
PLoS One. 2011;6(6):e21129. doi: 10.1371/journal.pone.0021129. Epub 2011 Jun 17.
PLoS One. 2011.
PMID: 21747904
Free PMC article.